Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using Patient Feedback to Improve Treatment Outcomes for Patients with Congenital Dyserythropoietic Anaemia Type I Receiving Interferon Therapy.

Journal of clinical medicine·2026
Same author

SHARK: A Specialized Host for Assembling R6K Plasmids.

ACS synthetic biology·2026
Same author

Emerging trends in genome integration tools for precision engineering of diverse bacterial species.

Synthetic biology (Oxford, England)·2026
Same author

The Influence of Race, Ethnicity and Historical Redlining on Psoriatic Disease Burden and Clinical Outcomes.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Where We Live Matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United States.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Drug Interaction Between Clozapine and Rifampicin: Experience in Management Strategies From a Case Report.

Journal of clinical psychopharmacology·2025
Same journal

Nurse-led interventions and care for people with bronchiectasis: a pilot study.

British journal of nursing (Mark Allen Publishing)·2026
Same journal

The importance of good communication.

British journal of nursing (Mark Allen Publishing)·2026
Same journal

The experience of menopause in the workplace.

British journal of nursing (Mark Allen Publishing)·2026
Same journal

Enhancing simulated practice learning placement experiences through peer facilitation: insights and lessons learnt.

British journal of nursing (Mark Allen Publishing)·2026
Same journal

Nursing theory, concepts and models: towards person-centred infection prevention and control.

British journal of nursing (Mark Allen Publishing)·2026
Same journal

The emergency department is breaking and leadership alone cannot fix it.

British journal of nursing (Mark Allen Publishing)·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

Acute oncology: a developing sub-specialty.

Alison Pugh1, Helen Rogerson2, Helen Cosh2

  • 1Clinical Nurse Manager for Haematology, Aneurin Bevan University Health Board, Newport, Gwent.

British Journal of Nursing (Mark Allen Publishing)
|September 11, 2015
PubMed
Summary
This summary is machine-generated.

Cancer patients admitted to hospital acutely unwell often lack specialist care, leading to suboptimal management. Acute oncology services are emerging to improve care for these vulnerable patients during critical times.

Keywords:
Emergency medicineReferral and consultationSepsisSpinal cord compression

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K

Area of Science:

  • Oncology
  • Hospital Medicine
  • Healthcare Management

Background:

  • Cancer patients frequently experience acute illness requiring emergency hospital admission.
  • These admissions can stem from cancer complications, treatment toxicities, or initial malignancy presentation.
  • Current management is often suboptimal due to non-specialist care and lack of established pathways.

Purpose of the Study:

  • To explore the development of the acute oncology service model.
  • To review literature on the evolution of acute oncology services.
  • To consider various methods for delivering acute oncology care.

Main Methods:

  • Literature review of the acute oncology model.
  • Analysis of service delivery methods.
  • Exploration of the developing sub-specialty.

Main Results:

  • The acute oncology service model has evolved to address care gaps.
  • This developing sub-specialty aims to improve acute cancer patient care.
  • Different service delivery methods are being considered.

Conclusions:

  • Acute oncology services represent a crucial development in cancer care.
  • Specialist input is vital for managing acutely unwell cancer patients.
  • Optimizing acute care pathways can improve patient outcomes and reduce healthcare burdens.